ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Compounded mAbs - Cancer Therapies

Berkshire Healthcare NHS Foundation Trust · Tender notice on Find a Tender

Tender information last checkedLast checked 2 Oct 2026, 01:56.

Opportunity overview

Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters’ Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framework via MPSC. Please note: we did not publish a preliminary market engagement notice (UK2) for the following reasons: - we are not seeking to further develop our requirements or procurement approach. - we have procured similar supply arrangements via the Open procedure and deployed similar conditions of participation and award criteria. These have yielded good results previously. - we have already prepared our tender pack (see attached), that detail standard NHS contractual terms which have been found to be acceptable to the supply chain. - we understand the likely suppliers who will be interested but the open notice approach gives opportunity to others looking to enter the mAbs supply market

Classification

  • CPV33600000 — Pharmaceutical products
  • CPV85149000 — Pharmacy services

Lots

  • Lot 1£170.6m
  • Lot 2£45.4m

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
PR BHFT 0715
Status
active
Procurement Method
open
Procurement Method Details
Open procedure
Main Procurement Category
services
Above Threshold
Yes
Has Recurrence
Yes
Published risks
The following have been identified as ‘Known Risks’: Denial of access to raw material medicines to Suppliers, which increases the cost of mAb compounds, dose bands or brands on the Framework Agreement. Where this can be demonstrated by the Supplier, the Price for affected mAbs will be agreed and the Framework Prices modified as a Variation which may result in the overall Framework Agreement value increasing.

Legal basis

Id
2023/54
Scheme
UKPGA

Techniques

Has Framework Agreement
Yes

Framework Agreement

Method
withoutReopeningCompetition
Type
open
Buyer Categories
The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS). See Contract Description.
Description
The Contracting Authorities reserve the right to maintain supply with the incumbent Supplier to maintain continuity of care for patients. Framework call-off rules require the highest ranked Supplier for each LOT will be approached first to provide Services. Only should the highest ranked Supplier not be able to meet the demand and provide an acceptable product, will the next highest ranked Supplier be approached.

Submission terms

Electronic Submission Policy
allowed

Languages

en

Tender Period

Ends
22 Jun 2026, 12:00

Enquiry period

Ends
16 Jun 2026, 12:00

Expected award period

Ends
16 Nov 2026, 23:59

Recurrence

Dates

Entry 1
Starts
2 Jul 2029, 23:59

Contract terms

Financial Terms
30 day payment terms as set out in the Tender Pack - see 'PR BHFT 0715 - ITT Open - Schedule 7 - Draft Contract'.

Amendments

Entry 1
Description
Change to tender period resulting in the following alteration: Enquiry deadline change to 16/06/2026, 12.00pm Tender submission deadline change to 22/06/26, 12.00pm
Id
043323-2026

Lots and requirements

Entry 1
Id
1
Title
Lot 1
Description
High Volume Products - 5 molecules / all brands
Status
active
Has Renewal
Yes
Has Options
Yes

Value

Including VAT
204,768,000
Amount
170,640,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
Procurement Specific Questionnaire
Description
Pass/Fail - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
0.01
Weight
percentageExact
Criterion 2
Type
quality
Name
Framework Agreement T&Cs Acceptance
Description
Pass/Fail - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
0.01
Weight
percentageExact
Criterion 3
Type
quality
Name
Technical Compliance/ Technical Capability/ Quality Assurance (40%)
Description
Technical Compliance / Technical Capability/ Quality Assurance. Responses to Technical Questions - see Tender Pack - ITT Instructions for detail. Note: MHRA Licensing is Pass/Fail

Numbers

Entry 1
Number
39.98
Weight
percentageExact
Criterion 4
Type
quality
Name
Social Value (10%)
Description
Responses to Social Value Questions - see Tender Pack - ITT Instructions for detail.

Numbers

Entry 1
Number
10
Weight
percentageExact
Criterion 5
Type
quality
Name
Shelf Life (15%)
Description
Shelf Life Assessment - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
15
Weight
percentageExact
Criterion 6
Type
price
Name
Price (35%)
Description
Assessment of Pricing Model - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
35
Weight
percentageExact

Selection criteria

Criteria

Criterion 1
Type
economic
Description
See Tender Pack
Criterion 2
Type
technical
Description
See Tender Pack

Suitability

Sme
Yes
Vcse
Yes

Contract period

Starts
1 Dec 2026, 00:00
Ends
30 Nov 2028, 23:59
Max Extent Date
30 Nov 2030, 23:59

Renewal

Description
Option for 2 x 12 month extension (maximum duration 4 years).

Options

Description
Option for 2 x 12 month extension (maximum duration 4 years).
Entry 2
Id
2
Title
Lot 2
Description
Lower Volume Products - 13 molecules / all brands
Status
active
Has Renewal
Yes
Has Options
Yes

Value

Including VAT
54,432,000
Amount
45,360,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Type
quality
Name
Procurement Specific Questionnaire
Description
Pass/Fail - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
0.01
Weight
percentageExact
Criterion 2
Type
quality
Name
Framework Agreement T&Cs Acceptance
Description
Pass/Fail - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
0.01
Weight
percentageExact
Criterion 3
Type
quality
Name
Technical Compliance/ Technical Capability/ Quality Assurance (40%)
Description
Technical Compliance / Technical Capability/ Quality Assurance. Responses to Technical Questions - see Tender Pack - ITT Instructions for detail. Note: MHRA Licensing is Pass/Fail

Numbers

Entry 1
Number
39.98
Weight
percentageExact
Criterion 4
Type
quality
Name
Social Value (10%)
Description
Responses to Social Value Questions - see Tender Pack - ITT Instructions for detail.

Numbers

Entry 1
Number
10
Weight
percentageExact
Criterion 5
Type
quality
Name
Shelf Life (15%)
Description
Shelf Life Assessment - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
15
Weight
percentageExact
Criterion 6
Type
price
Name
Price (35%)
Description
Assessment of Pricing Model - see Tender Pack - ITT Instructions for detail

Numbers

Entry 1
Number
35
Weight
percentageExact

Selection criteria

Criteria

Criterion 1
Type
economic
Description
See Tender Pack
Criterion 2
Type
technical
Description
See Tender Pack

Suitability

Sme
Yes
Vcse
Yes

Contract period

Starts
1 Dec 2026, 00:00
Ends
30 Nov 2028, 23:59
Max Extent Date
30 Nov 2030, 23:59

Renewal

Description
Option for 2 x 12 month extension (maximum duration 4 years).

Options

Description
Option for 2 x 12 month extension (maximum duration 4 years).

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKJ
Country
GB
Country Name
United Kingdom
Item 2
Id
2
Related Lot
2

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
85149000
Description
Pharmacy services

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKJ
Country
GB
Country Name
United Kingdom

Published documents

Entry 1
Id
A-15858
Document Type
biddingDocuments
Format
application/x-zip-compressed
Entry 2
Id
conflictOfInterest
Document Type
conflictOfInterest
Entry 3
Id
043323-2026
Document Type
tenderNotice
Notice Type
UK4
Description
Tender notice on Find a Tender
Published
12 May 2026, 09:47
Format
text/html

Buyer, suppliers and contacts

Organisation 1
Name
Berkshire Healthcare NHS Foundation Trust
Id
GB-PPON-PVLX-5425-VJZN

Identifier

Scheme
GB-PPON
Id
PVLX-5425-VJZN

Address

Street Address
London House, London Road
Locality
Bracknell
Postal Code
RG12 2UT
Country
GB
Country Name
United Kingdom
Region
UKJ11

Contact

Name
Neelan Moodley

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government

Recorded locations

  • Buyer location · Bracknell · UKJ11 · RG12 2UT · United Kingdom
  • Delivery location · UKJ · United Kingdom
  • Delivery location · UK · United Kingdom

Notice and amendment history

2 published notice versions reviewed by ProcuraAxis.

2 VERSIONS
  1. 042148-2026Tender notice on Find a Tender ·
  2. 043323-2026Tender notice on Find a Tender ·